Butorphanol tartrate (stadol): a review

Area of Science:

• Pharmacology
• Anesthesiology
• Pain Management

Background:

• Butorphanol tartrate is an analgesic with mixed agonist-antagonist activity at opiate receptors.
• Its receptor specificity theoretically limits respiratory depression, gastrointestinal side effects, and dependency risk compared to traditional opiates.
• Traditional opiates like morphine and meperidine are commonly used for moderate pain.

Purpose of the Study:

• To review the therapeutic applications and advantages of butorphanol tartrate.
• To highlight its utility in managing moderate pain and its favorable side effect profile.
• To discuss its use in various medical scenarios, including preoperative sedation, anesthesia, obstetric analgesia, and conscious sedation.

Main Methods:

• Literature review of butorphanol tartrate's pharmacological properties and clinical applications.
• Analysis of its efficacy and safety profile in comparison to traditional opioid analgesics.
• Examination of its use in diverse patient populations and medical settings.

Main Results:

• Butorphanol tartrate demonstrates efficacy in treating moderate pain, offering an advantage over traditional opiates.
• Its mixed agonist-antagonist activity contributes to a reduced risk of respiratory depression, gastrointestinal issues, and dependency.
• Clinical applications include preoperative sedation, anesthesia supplementation, postanesthesia care, obstetric analgesia, postpartum pain relief, and conscious sedation.
• Notably, its lack of euphoric effects is beneficial in emergency medicine for at-risk populations.
• It is also used for epidural and patient-controlled analgesia, especially in cases of opiate allergy.
• As a non-controlled substance, butorphanol tartrate reduces administrative burdens and liability associated with controlled narcotics.

Conclusions:

• Butorphanol tartrate is a valuable analgesic for moderate pain, offering a favorable safety and side effect profile.
• Its unique pharmacological properties and non-controlled status enhance its clinical utility and reduce administrative concerns.
• Butorphanol tartrate presents a versatile and advantageous alternative to traditional opioid analgesics in a wide range of medical applications.